BN PROSPEC® SYSTEM
Report
- Report Number
- 2517506-2016-00396
- Event Type
- Malfunction
- Date Received
- October 29, 2016
- Date of Event
- September 26, 2016
- Report Date
- November 21, 2016
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
- Product Code
- JZW
- PMA / PMN Number
- K001647
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AS
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
INITIAL MDR (2517506-2016-00396) WAS FILED ON 10/29/2016. CORRECTED INFORMATION (10/31/2016): SECTIONS MANUFACTURER NAME, CITY AND STATE AND MANUFACTURING SITE ADDRESS/PHONE FOR DEVICES WERE UPDATED WITH THE CORRECT MANUFACTURER NAME AND ADDRESS. A CORRECTED MDR WAS SUBMITTED UNDER THE APPROPRIATE MANUFACTURER REPORT NUMBER. THE CORRECT MANUFACTURER REPORT NUMBER SHOULD HAVE BEEN 9610806-2016-00036.
THE CAUSE OF THE DISCREPANT FLC RESULTS IS AN INSTRUMENT MALFUNCTION OF THE DILUENT PUMP. THE CUSTOMER RUNS IGG SUBCLASSES WITH A SIEMENS REAGENT AND MEASURES FREE LIGHT CHAIN (FLC) KAPPA AND LAMBDA WITH THE NON-SIEMENS BINDING SITE REAGENT ON THE BN PROSPEC. THE SIEMENS IGG SUBCLASSES REAGENTS WERE SHOWING QC RESULTS OUT OF LABORATORY RANGES BUT SOME OF THE FLC QC WAS WITHIN LABORATORY LIMITS. NO INSTRUMENT ERRORS WERE LOGGED. THE CUSTOMER WENT AHEAD AND RAN ALL FLC PATIENTS AND RELEASED THE RESULTS TO THE DOCTOR WHILE THE ANALYSER WAS FAILING THE DILUENT PUMP CALIBRATION. AS NO ERROR WAS DISPLAYED, THE OPERATOR CONTINUED RUNNING THE ANALYSER REPORTING OUT INCORRECT RESULTS FOR THE BINDING SITE FLC KAPPA AND LAMBDA. A FIELD ENGINEER REPLACED THE DILUENT PUMP AND RETURNED THE INSTRUMENT TO SERVICE. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED.
DISCREPANT FREE LIGHT CHAIN (FLC) RESULTS (KAPPA AND LAMBDA) WERE OBTAINED ON PATIENT SAMPLES WITH THE BINDING SITE FLC REAGENT ON THE BN PROSPEC INSTRUMENT. THE RESULTS WERE REPORTED TO THE PHYSICIAN WHO QUESTIONED THE RESULTS. AFTER AN INSTRUMENT MALFUNCTION WAS IDENTIFIED AND REPAIRED, THE SAME SAMPLES WERE REPEATED AND CORRECTED RESULTS WERE ISSUED. THERE IS NO INDICATION THAT PATIENT TREATMENT WAS ALTERED OR PRESCRIBED ON THE BASIS OF THE DISCREPANT FLC KAPPA AND LAMBDA RESULTS. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE DISCREPANT FLC KAPPA AND LAMBDA RESULTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 716719 | BN PROSPEC® SYSTEM | BN PROSPEC® SYSTEM | JZW | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH | BN PROSPEC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |